Kimbell Royalty Partners recently hit an all-time high of $15.82, driven by a 43.74% earnings beat in Q4 2025 and a 6% ...
Patient Capital Management, based in Baltimore, released its first-quarter 2026 investor letter for the “Patient Opportunity Equity Strategy,” available for download here. The strategy’s long-term ...
Zacks Investment Research on MSN
Can Royalty Pharma (RPRX) keep the earnings surprise streak alive?
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain ...
Transaction expands Chancery's gold royalty portfolio as the Company progresses toward a planned 2026 public listing ...
Oil crossed $100 a barrel on Sunday night after President Trump announced a U.S. Navy blockade of the Strait of Hormuz, ...
Aug 25 (Reuters) - Royalty Pharma (RPRX.O), opens new tab has agreed to buy a royalty interest in Amgen's (AMGN.O), opens new tab drug for small cell lung cancer from BeOne Medicines (688235.SS), ...
With its first FDA approval coming in August and a second expected next month for another of its treatments, these are exhilarating days for 19-year-old Syndax Pharmaceuticals as it transforms into a ...
An image such as a drawing or photograph is typically protected by copyright. If you want to use an image that you did not create, you generally must obtain specific ...
At the end of last week I paid a visit to the National Franchise Exhibition at the NEC in Birmingham (UK). As always, it was a great opportunity to meet with and chat to other franchisors, a chance to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results